Chronic terbutaline therapy and peripartum cardiomyopathy: A case-control study

Hypertension in Pregnancy

Volumn 15, Issue 2, 1996, Pages 183-191

  Hibbard, Judith U ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Peripartum cardiomyopathy; Terbutaline complication; Tocolytic complication; mimetic complication

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; TERBUTALINE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE CONTROL STUDY; CLINICAL ARTICLE; FEMALE; HUMAN; MATERNAL AGE; PREMATURE LABOR; REGRESSION ANALYSIS; SMOKING;

EID: 0029790084     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959609015701     Document Type: Article

References (25)

1. Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 1993; 168:493-5.
2. Leveno KJ, Klein VR, Guzick DS, Young DC, Hankins GDV, Williams ML. Single-centre randomised trial of ritodrine hydrochloride for preterm labour. Lancet 1986;i: 1293-6.
3. King JF, Grant A, Keirse MJN, Chalmers I. β-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 1988;95:211-22.
4. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-12.
5. Caritis S, Toig G, Heddinger L, Ashmead G. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. Am J Obstet Gynecol 1984; 150:7-14.
6. Walters W, Wood C. A trial of oral ritodrine for the prevention of premature labour. Br J Obstet Gynaecol 1977;84:26.
7. Main DM, Main EK. Preterm birth. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics Normal and Problem Pregnancies. 2nd ed. New York: Churchill Living-stone, 1991: 829-80.
8. Katz M, Robertson PA, Creasy RK. Cardiovascular complications associated with terbutaline treatment for preterm labor. Am J Obstet Gynecol 1981;139:605-8.
9. Benedetti TJ. Maternal complications of parenteral β-sympathomimetic therapy for premature labor. Am J Obstet Gynecol 1983;145:1-6.
10. Pisani RJ, Rosenow EC. Pulmonary edema associated with tocolytic therapy. Ann Int Med 1989;110:714-8.
11. Hankins GDV. Complications of beta-sympathomimetic tocolytic agents. In: Clark SL, Cotton DB, Hankins GDV, Phelan JP, eds. Critical Care Obstetrics. 2nd ed. Boston: Blackwell Scientific, 1991: 231-44.
12. Wagner JM, Morton MJ, Johnson KA, O'Grady JP, Speroff L. Terbutaline and maternal cardiac function. JAMA 1981;246:2697-701.
13. Finley J, Katz M, Rojas-Perez M, Roberts JM, Creasy RK, Schiller NB. Cardiovascular consequences of β-agonist tocolysis: an echocardiographic study. Obstet Gynecol 1984;64:787-91.
14. Katz VL, Seeds JW. Fetal and neonatal cardiovascular complications from β-sympathomimetic therapy for tocolysis. Am J Obstet Gynecol 1989;161:1-4.
15. Bohm N, Adler CP. Focal necrosis, fatty degeneration and subendocardial nuclear polyploidization in the myocardium in newborns. Eur J Pediatr 1981;136:149-57.
16. Milliez J, Blot PH, Sureau C. A case report of maternal death associated with betamimetics and betamethasone administration in premature labor. Eur J Obstet Gynecol Reprod Biol 1980;11:95-100.
17. Blickstein I, Zalel Y, Katz Z, Lancet M. Ritodrine-induced pulmonary edema unmasking underlying peripartum cardiomyopathy. Am J Obstet Gynecol 1988;159: 332-3.
18. Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughn ED. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with pheochromocyotoma. N Engl J Med 1987;316:793-7.
19. Jiang JP, Downing SE. Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med 1990;63:581-91.
20. Magnusson G, Hansson E. Myocardial necrosis in the rat: a comparison between isoprenaline, orciprenaline, salbutamol and terbutaline. Cardiology 1973;58:174-80.
21. Wedinger H, Wiest W, Schleich A, Hofmann W, Shroeter D. The effects of betamimetic drugs used for tocolysis on the fetal myocardium. J Perinat Med 1976;4: 280-5.
22. Cruz FES, Cheriex EC, Smeets JLRM, Atie J, Peres AK, Penn OCKM, Brugada P, Wellens HJJ. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol 1990;16:739-44.
23. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986;74:1290-1302.
24. Heilbrunn SM, Shah P, Bristow MR, Valatine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989;79:483-490.
25. Berg G, Anderssen RGG, Ryden G. Beta-adrenergic receptors in human myometruim during pregnancy: changes in the number of receptors after beta-mimetic treatment. Am J Obstet Gynecol 1985;151:392-6.